Seraph Clinical Evaluation

Help evaluate clinician-led ECG decision support.

HyperLXC Medical is preparing structured clinical evaluation of Seraph with registered clinicians, clinical safety stakeholders, and healthcare organisations.

Evaluation focus

  • Clinician review of AI-suggested ECG candidate findings.
  • Workflow usability across ECG analysis, patient context, and clinician sign-off.
  • Auditability, SNOMED CT coding, and EPR hand-off requirements.
  • Clinical-safety evidence to inform the DCB0129 and MHRA-registration pathway.
Who We Are Looking For

Clinical reviewers and evaluation partners

Registered clinicians

Cardiologists, cardiac physiologists, registrars, and cardiology-trained nurses interested in reviewing Seraph's candidate ECG findings.

Clinical safety teams

Clinical safety officers and governance leads who can advise on hazard analysis, sign-off workflows, and safety-case evidence.

Healthcare organisations

NHS and private providers interested in evaluation partnerships, workflow studies, or future EPR integration discussions.

Evaluation Scope

What participation may involve

Structured review

  • Reviewing ECG examples and Seraph candidate findings.
  • Comparing suggestions with clinician interpretation.
  • Recording usability, clarity, and workflow feedback.
  • Identifying areas requiring calibration or clearer rationale.

Governance input

  • Reviewing intended-use and oversight language.
  • Advising on audit-trail and override expectations.
  • Mapping evidence needs for procurement and clinical safety.
  • Discussing EPR, FHIR, and SNOMED CT hand-off requirements.

Important status note

Seraph is provisional clinical decision-support software in pre-market clinical evaluation. Outputs are AI-suggested and not part of the clinical record until formally reported by a registered clinician. Not for clinical use without clinician oversight. Seraph is not a CE/UKCA-marked medical device.

Interested in evaluating Seraph?

Tell us about your role, organisation, and whether you are interested in clinical review, safety governance, or evaluation partnership.

Contact the team